RTTNews

(RTTNews) – The U.S. Securities and Exchange Commission announced Cassava Sciences Inc. (SAVA), its founder and former CEO, Remi Barbier, and its former Senior Vice President of Neuroscience, Dr. Lindsay Burns, will pay more than $40 million to settle charges […]

(RTTNews) – Graco Inc. (GGG) announced that it agreed to acquire Corob S.p.A. for 230 million euros, subject to customary adjustments, with up to 30 million euros in additional contingent consideration. The transaction is expected to close in Graco’s fiscal

(RTTNews) – The Malaysia stock market on Thursday snapped the two-day winning streak in which is it had collected almost 10 points or 0.6 percent. The Kuala Lumpur Composite Index now rests just above the 1,670-point plateau although it’s expected

(RTTNews) – Mitchells & Butlers PLC (MAB.L, MLB), an operator of managed restaurants and pubs, reported Thursday that its total sales in the 51-week year to date period increased 5.9 percent on a reported basis, and grew 5.2 percent on

(RTTNews) – Mercer International Inc. (MERC) said that its Peace River mill has taken downtime to complete necessary repairs to the mill’s digester after experiencing a mechanical failure. The company now expects the repairs and related assessments will be completed

(RTTNews) – Merck & Co Inc. (MRK) on Wednesday said its Phase 3 KEYFORM-007 study evaluating the company’s drug candidate favezelimab in combination with Keytruda in patients with PD-L1 positive microsatellite stable (MSS) metastatic colorectal cancer (mCRC) did not meet

(RTTNews) – French Engineering & Technology company Technip Energies (THNPF, THNPY) announced Wednesday that it has received, along with engineering contractor JGC Corp., a Front-End Engineering Design or FEED contract by ExxonMobil (XOM) for the Rovuma LNG project at Palma

(RTTNews) – Arcutis Biotherapeutics Inc.’s (ARQT) ZORYVE cream 0.15% provided consistent and meaningful improvements in signs and symptoms of atopic dermatitis in individuals regardless of race, ethnicity, and Fitzpatrick skin types, as per subgroup analysis results from the Phase 3

(RTTNews) – Amgen (AMGN) said that Japan’s Ministry of Health, Labour and Welfare approved TEPEZZA (Teprotumumab) for the treatment of active or high clinical activity score (CAS) Thyroid Eye Disease or TED. In addition to Japan, TEPEZZA is currently approved